Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Harmony Biosciences Holdings, Inc.    HRMY

HARMONY BIOSCIENCES HOLDINGS, INC.

(HRMY)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
11/19/2020 11/20/2020 11/23/2020 11/24/2020 11/25/2020 Date
42.53(c) 43.66(c) 42.6(c) 46.65(c) 49.56(c) Last
195 009 219 764 252 218 186 657 186 102 Volume
-0.68% +2.66% -2.43% +9.51% +6.24% Change
More quotes
Financials (USD)
Sales 2020 155 M - -
Net income 2020 -33,5 M - -
Net Debt 2020 28,9 M - -
P/E ratio 2020 -85,4x
Yield 2020 -
Sales 2021 300 M - -
Net income 2021 66,7 M - -
Net Debt 2021 139 M - -
P/E ratio 2021 45,3x
Yield 2021 -
Capitalization 2 819 M 2 819 M -
EV / Sales 2020 18,3x
EV / Sales 2021 9,85x
Nbr of Employees 150
Free-Float 81,1%
More Financials
Company
Harmony Biosciences Holdings, Inc. is a holding company. The Company through its subsidiary, Harmony Biosciences, LLC., operates as a pharmaceutical company, which is focused on therapies for patients suffering from central nervous system disorders living with medical needs. It provides treatment options for people living with rare and orphan diseases, with an emphasis on central nervous system disorders, patients... 
Sector
Pharmaceuticals
Calendar
-
More about the company
All news about HARMONY BIOSCIENCES HOLDINGS, INC.
11/13HARMONY BIOSCIENCES : Reports third quarter 2020 financial results and business ..
AQ
11/12HARMONY BIOSCIENCES : Management's Discussion and Analysis of Financial Conditio..
AQ
11/12HARMONY BIOSCIENCES HOLDINGS, INC. : Results of Operations and Financial Conditi..
AQ
11/12HARMONY BIOSCIENCES : Reports Third Quarter 2020 Financial Results and Business ..
AQ
11/12Harmony Biosciences Reports Third Quarter 2020 Financial Results and Busines..
GL
11/12HARMONY BIOSCIENCES HOLDINGS, INC. : Change in Directors or Principal Officers, ..
AQ
11/11HARMONY BIOSCIENCES : Appoints Mark Graf And Eric Motley To Its Board Of Directo..
PR
10/29HARMONY BIOSCIENCES : Announces date of third quarter 2020 financial results
AQ
10/28HARMONY BIOSCIENCES : Announces Date Of Third Quarter 2020 Financial Results
PR
10/15HARMONY BIOSCIENCES : Receives fda approval for expanded use of wakix for the tr..
AQ
10/14HARMONY BIOSCIENCES HOLDINGS, INC. : Creation of a Direct Financial Obligation o..
AQ
10/14HARMONY BIOSCIENCES : Receives FDA Approval For Expanded Use Of WAKIX® (pitolisa..
PR
09/23HARMONY BIOSCIENCES : Announces recipients of 2020 patients at the heart grant o..
AQ
09/22HARMONY BIOSCIENCES : Announces Recipients Of 2020 Patients At The Heart Grant O..
PR
09/01HARMONY BIOSCIENCES HOLDINGS, INC. : Unregistered Sale of Equity Securities, Oth..
AQ
More news
News in other languages on HARMONY BIOSCIENCES HOLDINGS, INC.

- No features available -

More news
Chart HARMONY BIOSCIENCES HOLDINGS, INC.
Duration : Period :
Harmony Biosciences Holdings, Inc. Technical Analysis Chart | HRMY | US4131971040 | MarketScreener
Technical analysis trends HARMONY BIOSCIENCES HOLDINGS, INC.
Short TermMid-TermLong Term
TrendsNeutralNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 3
Average target price 52,00 $
Last Close Price 49,56 $
Spread / Highest target 23,1%
Spread / Average Target 4,92%
Spread / Lowest Target -17,3%
EPS Revisions
Managers
NameTitle
John C.s Jacobs President, Chief Executive Officer & Director
Jeffrey S. Aronin Non-Executive Chairman
Susan L. Drexler Chief Financial Officer
Jeffrey M. Dayno Chief Medical Officer
Martin W. Edwards Director
Sector and Competitors
1st jan.Capitalization (M$)
HARMONY BIOSCIENCES HOLDINGS, INC.0.00%2 819
JOHNSON & JOHNSON-1.50%378 744
ROCHE HOLDING AG-4.28%281 946
PFIZER INC.-1.59%203 437
MERCK & CO., INC.-11.89%202 757
NOVARTIS AG-12.66%200 273